Cambridge University Hospitals Foundation NHS Trust

Cambridge CB2 0QQ

0 studies enrolling now · 1 studies all time

What they study most

Alpha 1-Antitrypsin Deficiency, COPD, Emphysema

Studies at this site

• A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo. — Completed